BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11731153)

  • 1. Folic acid utilisation related to sulfa drug resistance in Saccharomyces cerevisiae.
    Bayly AM; Berglez JM; Patel O; Castelli LA; Hankins EG; Coloe P; Hopkins Sibley C; Macreadie IG
    FEMS Microbiol Lett; 2001 Nov; 204(2):387-90. PubMed ID: 11731153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
    Iliades P; Berglez J; Meshnick S; Macreadie I
    Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
    Patel O; Karnik K; Macreadie IG
    FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of dihydropteroate in Saccharomyces cerevisiae.
    Bayly AM; Macreadie IG
    FEMS Microbiol Lett; 2002 Aug; 213(2):189-92. PubMed ID: 12167536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
    Meneau I; Sanglard D; Bille J; Hauser PM
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2610-6. PubMed ID: 15215117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae.
    Moukhlis R; Boyer J; Lacube P; Bolognini J; Roux P; Hennequin C
    Clin Microbiol Infect; 2010 May; 16(5):501-7. PubMed ID: 19673964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition studies of sulfonamide-containing folate analogs in yeast.
    Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
    Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system.
    Iliades P; Meshnick SR; Macreadie IG
    Microb Drug Resist; 2005; 11(1):1-8. PubMed ID: 15770087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfa drug screening in yeast: fifteen sulfa drugs compete with p-aminobenzoate in Saccharomyces cerevisiae.
    Castelli LA; Nguyen NP; Macreadie IG
    FEMS Microbiol Lett; 2001 May; 199(2):181-4. PubMed ID: 11377864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid antagonism of sulfa drug treatments.
    Bayly AM; Macreadie IG
    Trends Parasitol; 2002 Feb; 18(2):49-50. PubMed ID: 11832284
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyglutamylation of folate coenzymes is necessary for methionine biosynthesis and maintenance of intact mitochondrial genome in Saccharomyces cerevisiae.
    Cherest H; Thomas D; Surdin-Kerjan Y
    J Biol Chem; 2000 May; 275(19):14056-63. PubMed ID: 10799479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
    Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs.
    Djapa LY; Zelikson R; Delahodde A; Bolotin-Fukuhara M; Mazabraud A
    FEMS Microbiol Lett; 2006 Mar; 256(1):105-11. PubMed ID: 16487326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Saccharomyces cerevisiae Fol1 protein: starvation for C1 carrier induces pseudohyphal growth.
    Güldener U; Koehler GJ; Haussmann C; Bacher A; Kricke J; Becher D; Hegemann JH
    Mol Biol Cell; 2004 Aug; 15(8):3811-28. PubMed ID: 15169867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B3 confers resistance to sulfa drugs in Saccharomyces cerevisiae.
    Kornfeld O; Nichols BP
    FEMS Microbiol Lett; 2005 Oct; 251(1):137-41. PubMed ID: 16112818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfa drugs strike more than once.
    Patel OG; Mberu EK; Nzila AM; Macreadie IG
    Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
    [No Abstract]   [Full Text] [Related]  

  • 19. The sequence diversity and expression among genes of the folic acid biosynthesis pathway in industrial Saccharomyces strains.
    Goncerzewicz A; Misiewicz A
    Acta Biochim Pol; 2015; 62(4):841-50. PubMed ID: 26610311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folates in plasma and bile of man after feeding folic acid--3H and 5-formyltetrahydrofolate (folinic acid).
    Pratt RF; Cooper BA
    J Clin Invest; 1971 Feb; 50(2):455-62. PubMed ID: 4992993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.